Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Sales | 25,070 | 23,036 | 19,545 | 19,683 | 19,483 |
| Cost of Goods | 14,892 | 12,584 | 12,587 | 15,543 | 11,248 |
| Gross Profit | 10,179 | 10,453 | 6,958 | 4,140 | 8,235 |
| Operating Expenses | 5,946 | 5,408 | 5,443 | 6,100 | 4,791 |
| Operating Income | 4,233 | 5,045 | 1,515 | -1,960 | 3,444 |
| Interest Expense | 1,051 | 949 | 1,367 | 1,376 | 1,208 |
| Other Income | -149 | -296 | 1,875 | -111 | -129 |
| Pre-tax Income | 3,034 | 3,800 | 2,023 | -3,447 | 2,107 |
| Income Tax | 728 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 2,306 | 5,754 | 2,023 | -3,447 | 2,107 |
| Net Income | $2,306 | $5,754 | $2,023 | $-3,447 | $2,107 |
| EPS Basic Total Ops | 0.03 | 0.06 | 0.02 | -0.04 | 0.02 |
| EPS Basic Continuous Ops | 0.03 | 0.06 | 0.02 | -0.04 | 0.02 |
| EPS Diluted Total Ops | 0.03 | 0.06 | 0.02 | -0.04 | 0.02 |
| EPS Diluted Continuous Ops | 0.03 | 0.06 | 0.02 | -0.04 | 0.02 |
| EBITDA(a) | $5,638 | $6,519 | $4,903 | $-617 | $4,931 |